AbbVie <ABBV.N>: Canaccord Genuity Raises Target Price to $282 From $273
ABBV•Related News
Adtran Holdings Says Preliminary Q2 2026 Revenue Expected At $280 Million-$282 Million
ADTN•
Danaher Corp <DHR.N>: TD Cowen cuts target price to $236 from $240
DHR•
Companies race to deliver autonomous uncrewed fighter jets
BA•
Equifax Inc <EFX.N>: RBC cuts target price to $194 from $222
EFX•
Turning Point Brands Inc <TPB.N>: BTIG initiates coverage with buy rating; price target $103
TPB•